Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #51 to #100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Section 2.1: Lessons from animal models (from DOI: 10.1016/j.jcv.2020.104372): Title
  2. Section 2: Is SARS-CoV-2 a congenital or perinatally-acquired pathogen for the neonate? (from DOI: 10.1016/j.jcv.2020.104372): Title
  3. Section 1: Introduction (from DOI: 10.1016/j.jcv.2020.104372): Title
  4. Conflict of Interest (from DOI: 10.1007/s11886-020-01293-2): Title
  5. Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2): Title
  6. Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2): Title
  7. Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2): Title
  8. Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2): Title
  9. Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2): Title
  10. Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2): Title
  11. Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2): Title
  12. Section 6: Conclusions (from DOI:10.14218/ERHM.2020.00023): Title
  13. Section 5: Future directions (from DOI:10.14218/ERHM.2020.00023): Title
  14. Section 4: Discussion (from DOI:10.14218/ERHM.2020.00023): Title
  15. Section 3: Results (from DOI:10.14218/ERHM.2020.00023): Title
  16. Section 2: Methods (from DOI:10.14218/ERHM.2020.00023): Title
  17. Section 1: Introduction (from DOI:10.14218/ERHM.2020.00023): Title
  18. Meyers LA (7th author of DOI /10.3201/eid2605.200146): Title
  19. Cowling B (6th author of DOI /10.3201/eid2605.200146): Title
  20. Wang X (5th author of DOI /10.3201/eid2605.200146): Title
  21. Xu X(4th author of DOI /10.3201/eid2605.200146): Title
  22. Cauchemez S (3rd author of DOI /10.3201/eid2605.200146): Title
  23. Wang L (2nd author of DOI /10.3201/eid2605.200146): Title
  24. Du Z (1st author of DOI /10.3201/eid2605.200146): Title
  25. Zanoni I (16th author of DOI: 10.1084/jem.20200653): Title
  26. Wack A (15th author of DOI: 10.1084/jem.20200653): Title
  27. Reich NC (14th author of DOI: 10.1084/jem.20200653): Title
  28. Santer DM (13th author of DOI: 10.1084/jem.20200653): Title
  29. Piontkivska H (12th author of DOI: 10.1084/jem.20200653): Title
  30. Onabajo OO (11th author of DOI: 10.1084/jem.20200653): Title
  31. Odendall C (10th author of DOI: 10.1084/jem.20200653): Title
  32. O'Brien TR (9th author of DOI: 10.1084/jem.20200653): Title
  33. Lazear HM (8th author of DOI: 10.1084/jem.20200653): Title
  34. Kotenko SV (7th author of DOI: 10.1084/jem.20200653): Title
  35. Hartmann R (6th author of DOI: 10.1084/jem.20200653): Title
  36. Glenn JS (5th author of DOI: 10.1084/jem.20200653): Title
  37. Durbin JE (4th author of DOI: 10.1084/jem.20200653): Title
  38. Dickenson RE (3rd author of DOI: 10.1084/jem.20200653): Title
  39. Alphonse N (2nd author of DOI: 10.1084/jem.20200653): Title
  40. Prokunina-Olsson L (1st author of DOI: 10.1084/jem.20200653): Title
  41. COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653): Title
  42. Schleiss MR (4th author of DOI: 10.1016/j.jcv.2020.104372): Title
  43. Pesch MH (3rd author of DOI: 10.1016/j.jcv.2020.104372): Title
  44. Fowler KB (2nd author of DOI: 10.1016/j.jcv.2020.104372): Title
  45. Muldoon KM (1st author of DOI: 10.1016/j.jcv.2020.104372): Title
  46. Rhee JW (7th author of DOI: 10.1007/s11886-020-01293-2): Title
  47. Wu SM (6th author of DOI: 10.1007/s11886-020-01293-2): Title
  48. Quertermous T (5th author of DOI: 10.1007/s11886-020-01293-2): Title
  49. Wu JC (4th author of DOI: 10.1007/s11886-020-01293-2): Title
  50. Witteles RM (3rd author of DOI: 10.1007/s11886-020-01293-2): Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)